We are analyzing https://link.springer.com/article/10.1007/s00018-005-5398-3.

Title:
Liver X receptors in cardiovascular and metabolic disease | Cellular and Molecular Life Sciences
Description:
Liver X receptors (LXRs) α and β are nuclear oxysterol receptors and metabolic sensors initially found to regulate cholesterol metabolism and lipid biosynthesis. Recent studies have elucidated the importance of LXR in the development of cardiovascular diseases and metabolic disorders. LXR agonists prevent development of atherosclerosis by modulation of metabolic as well as inflammatory gene expression in rodent models. Moreover, LXR activation inhibits hepatic gluconeogenesis and lowers serum glucose levels, indicating possible application of LXR activation in the treatment of diabetes mellitus. However, first-generation LXR agonists elevate hepatic and serum trigylceride levels, making subtype-specific agonists and selective LXR modulators rather than unselective LXR agonists a potential pharmacological strategy. This review summarizes the multiple physiological and pathophysiological implications of LXRs and observations that identify LXRs as potential targets for therapeutic interventions in human cardiovascular and metabolic disease.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Health & Fitness
Science
Mobile Technology & AI

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,626,932 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't figure out the monetization strategy.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com could be getting rich in stealth mode, or the way it's monetizing isn't detectable.

Keywords {🔍}

article, metabolic, lxr, receptors, cardiovascular, liver, disease, privacy, cookies, content, stulnig, agonists, information, publish, search, geyeregger, access, data, log, journal, research, molecular, life, sciences, february, zeyda, lxrs, hepatic, receptor, discover, author, vienna, springer, optional, personal, parties, policy, find, track, cellular, review, published, cite, explore, nuclear, metabolism, lipid, development, diseases, atherosclerosis,

Topics {✒️}

nuclear oxysterol receptors making subtype-specific agonists month download article/chapter diabetes mellitus privacy choices/manage cookies metabolic disease lipid signalling serum trigylceride levels unselective lxr agonists full article pdf cardiovascular disease selective lxr modulators european economic area scope submit manuscript inflammatory gene expression related subjects author correspondence conditions privacy policy receptor potential pharmacological strategy accepting optional cookies cardiovascular diseases regulate cholesterol metabolism journal finder publish check access instant access metabolic disorders lxr agonists lxr activation article cellular privacy policy personal data molecular medicine life sci human cardiovascular atherosclerosis books a article log receptors information optional cookies article number 524 manage preferences metabolic review summarizes subscription content similar content data protection essential cookies cookies skip

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Liver X receptors in cardiovascular and metabolic disease
         description:Liver X receptors (LXRs) α and β are nuclear oxysterol receptors and metabolic sensors initially found to regulate cholesterol metabolism and lipid biosynthesis. Recent studies have elucidated the importance of LXR in the development of cardiovascular diseases and metabolic disorders. LXR agonists prevent development of atherosclerosis by modulation of metabolic as well as inflammatory gene expression in rodent models. Moreover, LXR activation inhibits hepatic gluconeogenesis and lowers serum glucose levels, indicating possible application of LXR activation in the treatment of diabetes mellitus. However, first-generation LXR agonists elevate hepatic and serum trigylceride levels, making subtype-specific agonists and selective LXR modulators rather than unselective LXR agonists a potential pharmacological strategy. This review summarizes the multiple physiological and pathophysiological implications of LXRs and observations that identify LXRs as potential targets for therapeutic interventions in human cardiovascular and metabolic disease.
         datePublished:2006-02-02T00:00:00Z
         dateModified:2006-02-02T00:00:00Z
         pageStart:524
         pageEnd:539
         sameAs:https://doi.org/10.1007/s00018-005-5398-3
         keywords:
            Liver X receptor
            macrophages
            atherosclerosis
            cardiovascular disease
            diabetes mellitus
            metabolic syndrome
            Cell Biology
            Biomedicine
            general
            Life Sciences
            Biochemistry
         image:
         isPartOf:
            name:Cellular and Molecular Life Sciences
            issn:
               1420-9071
               1420-682X
            volumeNumber:63
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Birkhäuser-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:R. Geyeregger
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
                     address:
                        name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:M. Zeyda
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. M. Stulnig
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
                     address:
                        name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Liver X receptors in cardiovascular and metabolic disease
      description:Liver X receptors (LXRs) α and β are nuclear oxysterol receptors and metabolic sensors initially found to regulate cholesterol metabolism and lipid biosynthesis. Recent studies have elucidated the importance of LXR in the development of cardiovascular diseases and metabolic disorders. LXR agonists prevent development of atherosclerosis by modulation of metabolic as well as inflammatory gene expression in rodent models. Moreover, LXR activation inhibits hepatic gluconeogenesis and lowers serum glucose levels, indicating possible application of LXR activation in the treatment of diabetes mellitus. However, first-generation LXR agonists elevate hepatic and serum trigylceride levels, making subtype-specific agonists and selective LXR modulators rather than unselective LXR agonists a potential pharmacological strategy. This review summarizes the multiple physiological and pathophysiological implications of LXRs and observations that identify LXRs as potential targets for therapeutic interventions in human cardiovascular and metabolic disease.
      datePublished:2006-02-02T00:00:00Z
      dateModified:2006-02-02T00:00:00Z
      pageStart:524
      pageEnd:539
      sameAs:https://doi.org/10.1007/s00018-005-5398-3
      keywords:
         Liver X receptor
         macrophages
         atherosclerosis
         cardiovascular disease
         diabetes mellitus
         metabolic syndrome
         Cell Biology
         Biomedicine
         general
         Life Sciences
         Biochemistry
      image:
      isPartOf:
         name:Cellular and Molecular Life Sciences
         issn:
            1420-9071
            1420-682X
         volumeNumber:63
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Birkhäuser-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:R. Geyeregger
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
                  address:
                     name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:M. Zeyda
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. M. Stulnig
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
                  address:
                     name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cellular and Molecular Life Sciences
      issn:
         1420-9071
         1420-682X
      volumeNumber:63
Organization:
      name:Birkhäuser-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Medical University of Vienna
      address:
         name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
      address:
         name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
      address:
         name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:R. Geyeregger
      affiliation:
            name:Medical University of Vienna
            address:
               name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
            address:
               name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:M. Zeyda
      affiliation:
            name:Medical University of Vienna
            address:
               name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:T. M. Stulnig
      affiliation:
            name:Medical University of Vienna
            address:
               name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences
            address:
               name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
      name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
      name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
      name:Clin. Div. of Endocrinology and Metabolism, Dept. of Internal Med. III, Medical University of Vienna, Vienna, Austria
      name:CeMM — Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(29)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.75s.

LINK . SPRINGER . COM {}